GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation

Summary: Hypertrophic white adipose tissue (WAT) represents a maladaptive mechanism linked to the risk for developing type 2 diabetes in humans. However, the molecular events that predispose WAT to hypertrophy are poorly defined. Here, we demonstrate that adipocyte hypertrophy is triggered by loss o...

Full description

Bibliographic Details
Main Authors: Karima Drareni, Raphaëlle Ballaire, Serena Barilla, Mano J. Mathew, Amine Toubal, Rongrong Fan, Ning Liang, Catherine Chollet, Zhiqiang Huang, Maria Kondili, Fabienne Foufelle, Antoine Soprani, Ronan Roussel, Jean-François Gautier, Fawaz Alzaid, Eckardt Treuter, Nicolas Venteclef
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124718313032
_version_ 1819289608221884416
author Karima Drareni
Raphaëlle Ballaire
Serena Barilla
Mano J. Mathew
Amine Toubal
Rongrong Fan
Ning Liang
Catherine Chollet
Zhiqiang Huang
Maria Kondili
Fabienne Foufelle
Antoine Soprani
Ronan Roussel
Jean-François Gautier
Fawaz Alzaid
Eckardt Treuter
Nicolas Venteclef
author_facet Karima Drareni
Raphaëlle Ballaire
Serena Barilla
Mano J. Mathew
Amine Toubal
Rongrong Fan
Ning Liang
Catherine Chollet
Zhiqiang Huang
Maria Kondili
Fabienne Foufelle
Antoine Soprani
Ronan Roussel
Jean-François Gautier
Fawaz Alzaid
Eckardt Treuter
Nicolas Venteclef
author_sort Karima Drareni
collection DOAJ
description Summary: Hypertrophic white adipose tissue (WAT) represents a maladaptive mechanism linked to the risk for developing type 2 diabetes in humans. However, the molecular events that predispose WAT to hypertrophy are poorly defined. Here, we demonstrate that adipocyte hypertrophy is triggered by loss of the corepressor GPS2 during obesity. Adipocyte-specific GPS2 deficiency in mice (GPS2 AKO) causes adipocyte hypertrophy, inflammation, and mitochondrial dysfunction during surplus energy. This phenotype is driven by HIF1A activation that orchestrates inadequate WAT remodeling and disrupts mitochondrial activity, which can be reversed by pharmacological or genetic HIF1A inhibition. Correlation analysis of gene expression in human adipose tissue reveals a negative relationship between GPS2 and HIF1A, adipocyte hypertrophy, and insulin resistance. We propose therefore that the obesity-associated loss of GPS2 in adipocytes predisposes for a maladaptive WAT expansion and a pro-diabetic status in mice and humans. : Drareni et al. identify a role for the transcriptional corepressor GPS2 in the regulation of adipocyte hypertrophy. They provide evidence that adipocyte-specific loss of GPS2 predisposes toward maladaptive adipose tissue expansion and pro-diabetic status through activation of HIF1A transcriptional activity. Keywords: corepressor, transcription, adipose tissue, obesity, type 2 diabetes, insulin resistance, GPS2, HIF1A
first_indexed 2024-12-24T03:09:33Z
format Article
id doaj.art-326c110314a9499289414635556a19cd
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-24T03:09:33Z
publishDate 2018-09-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-326c110314a9499289414635556a19cd2022-12-21T17:17:53ZengElsevierCell Reports2211-12472018-09-01241129572971.e6GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A ActivationKarima Drareni0Raphaëlle Ballaire1Serena Barilla2Mano J. Mathew3Amine Toubal4Rongrong Fan5Ning Liang6Catherine Chollet7Zhiqiang Huang8Maria Kondili9Fabienne Foufelle10Antoine Soprani11Ronan Roussel12Jean-François Gautier13Fawaz Alzaid14Eckardt Treuter15Nicolas Venteclef16INSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, FranceINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France; Inovarion, 75013 Paris, FranceKarolinska Institutet, Department of Biosciences and Nutrition, Huddinge, SwedenINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, FranceINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, FranceKarolinska Institutet, Department of Biosciences and Nutrition, Huddinge, SwedenKarolinska Institutet, Department of Biosciences and Nutrition, Huddinge, SwedenINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, FranceKarolinska Institutet, Department of Biosciences and Nutrition, Huddinge, SwedenINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, FranceINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, FranceINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France; Clinique Geoffroy Saint-Hilaire, Ramsey General de Santé, Paris, FranceINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France; Diabetology, Endocrinology and Nutrition Department, DHU FIRE, Bichat Hospital, AP-HP, Paris, France; Faculty of Medicine, University Paris-Diderot, Paris, FranceINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France; Assistance Publique-Hôpitaux de Paris, Lariboisière Hospital, Department of Diabetes, Clinical Investigation Centre (CIC-9504), University Paris-Diderot, Paris, France; Faculty of Medicine, University Paris-Diderot, Paris, FranceINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, FranceKarolinska Institutet, Department of Biosciences and Nutrition, Huddinge, Sweden; Corresponding authorINSERM, Cordeliers Research Centre, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France; Corresponding authorSummary: Hypertrophic white adipose tissue (WAT) represents a maladaptive mechanism linked to the risk for developing type 2 diabetes in humans. However, the molecular events that predispose WAT to hypertrophy are poorly defined. Here, we demonstrate that adipocyte hypertrophy is triggered by loss of the corepressor GPS2 during obesity. Adipocyte-specific GPS2 deficiency in mice (GPS2 AKO) causes adipocyte hypertrophy, inflammation, and mitochondrial dysfunction during surplus energy. This phenotype is driven by HIF1A activation that orchestrates inadequate WAT remodeling and disrupts mitochondrial activity, which can be reversed by pharmacological or genetic HIF1A inhibition. Correlation analysis of gene expression in human adipose tissue reveals a negative relationship between GPS2 and HIF1A, adipocyte hypertrophy, and insulin resistance. We propose therefore that the obesity-associated loss of GPS2 in adipocytes predisposes for a maladaptive WAT expansion and a pro-diabetic status in mice and humans. : Drareni et al. identify a role for the transcriptional corepressor GPS2 in the regulation of adipocyte hypertrophy. They provide evidence that adipocyte-specific loss of GPS2 predisposes toward maladaptive adipose tissue expansion and pro-diabetic status through activation of HIF1A transcriptional activity. Keywords: corepressor, transcription, adipose tissue, obesity, type 2 diabetes, insulin resistance, GPS2, HIF1Ahttp://www.sciencedirect.com/science/article/pii/S2211124718313032
spellingShingle Karima Drareni
Raphaëlle Ballaire
Serena Barilla
Mano J. Mathew
Amine Toubal
Rongrong Fan
Ning Liang
Catherine Chollet
Zhiqiang Huang
Maria Kondili
Fabienne Foufelle
Antoine Soprani
Ronan Roussel
Jean-François Gautier
Fawaz Alzaid
Eckardt Treuter
Nicolas Venteclef
GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation
Cell Reports
title GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation
title_full GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation
title_fullStr GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation
title_full_unstemmed GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation
title_short GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation
title_sort gps2 deficiency triggers maladaptive white adipose tissue expansion in obesity via hif1a activation
url http://www.sciencedirect.com/science/article/pii/S2211124718313032
work_keys_str_mv AT karimadrareni gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT raphaelleballaire gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT serenabarilla gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT manojmathew gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT aminetoubal gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT rongrongfan gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT ningliang gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT catherinechollet gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT zhiqianghuang gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT mariakondili gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT fabiennefoufelle gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT antoinesoprani gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT ronanroussel gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT jeanfrancoisgautier gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT fawazalzaid gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT eckardttreuter gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation
AT nicolasventeclef gps2deficiencytriggersmaladaptivewhiteadiposetissueexpansioninobesityviahif1aactivation